Now Is the Time to Make Screening for Lung Cancer Reportable
Authors: Gregory C. Kane, Julie A. Barta, Christine S. Shusted, Nathaniel R. Evans
Journal: Annals of Internal Medicine (2022)

Ideas and OpinionsJune 2022Now Is the Time to Make Screening for Lung Cancer ReportableGregory C. Kane, MD, Julie A. Barta, MD, Christine S. Shusted, MPH, and Nathaniel R. Evans, MDGregory C. Kane, MDThe Jefferson-National Jewish Health Korman Respiratory Institute, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania (G.C.K., J.A.B., C.S.S.)Search for more papers by this author, Julie A. Barta, MDThe Jefferson-National Jewish Health Korman Respiratory Institute, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania (G.C.K., J.A.B., C.S.S.)Search for more papers by this author, Christine S. Shusted, MPHThe Jefferson-National Jewish Health Korman Respiratory Institute, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania (G.C.K., J.A.B., C.S.S.)Search for more papers by this author, and Nathaniel R. Evans, MDThe Jefferson-National Jewish Health Korman Respiratory Institute, Department of Surgery, Division of Thoracic Surgery, Philadelphia, Pennsylvania (N.R.E.).Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M22-0142 Annals Author Insight Video - Gregory C. Kane, MD; Nathaniel R. Evans, MD; Julie A. Barta, MD; and Christine S. Shusted, MPH In this video, Gregory C. Kane, MD; Nathaniel R. Evans, MD; Julie A. Barta, MD; and Christine S. Shusted, MPH, offer additional insight into the article, "Now Is the Time to Make Screening for Lung Cancer Reportable." (Duration 2:17) SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail As with many medical advancements, the mantra of “measure and report” was revolutionary at its inception but remains as critical today as ever. Performance metrics have improved quality standards for basic health care services such as screening mammography, diabetes control measures, and immunizations for more than 2 decades (1). In fact, a majority of Americans are enrolled in health plans that report Healthcare Effectiveness Data and Information Set (HEDIS) measures as a reflection of health care quality. These HEDIS data sets, developed and reported by the National Committee for Quality Assurance (NCQA), are intended to provide both purchasers and health ...References1. National Committee for Quality Assurance. 1997: NCQA's First State of Health Care Quality Report. 16 July 2015. Accessed at https://blog.ncqa.org/1997-ncqas-first-state-of-health-care-quality-report on 7 December 2021. Google Scholar2. Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7-33. [PMID: 35020204] doi:10.3322/caac.21708 CrossrefMedlineGoogle Scholar3. Aberle DR, Adams AM, Berg CD, et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409. [PMID: 21714641] doi:10.1056/NEJMoa1102873 CrossrefMedlineGoogle Scholar4. Centers for Medicare & Medicaid Services. Screening for Lung Cancer with Low Dose Computed Tomography (LDCT). Accessed at www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&ncaid=304 on 18 February 2022. Google Scholar5. de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382:503-13. [PMID: 31995683] doi:10.1056/NEJMoa1911793 CrossrefMedlineGoogle Scholar6. Krist AH, Davidson KW, Mangione CM, et al; US Preventive Services Task Force. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325:962-70. [PMID: 33687470] doi:10.1001/jama.2021.1117 CrossrefMedlineGoogle Scholar7. Jemal A, Fedewa SA. Lung cancer screening with low-dose computed tomography in the United States—2010 to 2015 [Letter]. JAMA Oncol. 2017;3:1278-81. [PMID: 28152136] doi:10.1001/jamaoncol.2016.6416 CrossrefMedlineGoogle Scholar8. Fedewa SA, Kazerooni EA, Studts JL, et al. State variation in low-dose computed tomography scanning for lung cancer screening in the United States. J Natl Cancer Inst. 2021;113:1044-52. [PMID: 33176362] doi:10.1093/jnci/djaa170 CrossrefMedlineGoogle Scholar9. Rivera MP, Katki HA, Tanner NT, et al. Addressing disparities in lung cancer screening eligibility and healthcare access. An official American Thoracic Society statement. Am J Respir Crit Care Med. 2020;202:e95-e112. [PMID: 33000953] doi:10.1164/rccm.202008-3053ST CrossrefMedlineGoogle Scholar10. Mazzone PJ, White CS, Kazerooni EA, et al. Proposed quality metrics for lung cancer screening programs: a National Lung Cancer Roundtable project. Chest. 2021;160:368-78. [PMID: 33539838] doi:10.1016/j.chest.2021.01.063 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Gregory C. Kane, MD; Julie A. Barta, MD; Christine S. Shusted, MPH; Nathaniel R. Evans, MDAffiliations: The Jefferson-National Jewish Health Korman Respiratory Institute, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania (G.C.K., J.A.B., C.S.S.)The Jefferson-National Jewish Health Korman Respiratory Institute, Department of Surgery, Division of Thoracic Surgery, Philadelphia, Pennsylvania (N.R.E.).Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M22-0142.Corresponding Author: Gregory C. Kane, MD, The Jane and Leonard Korman Professor of Pulmonary Medicine, The Jefferson-National Jewish Health Respiratory Institute, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, 1025 Walnut Street, Suite 822, Philadelphia, PA 19107; e-mail, Gregory.[email protected]edu.Author Contributions: Conception and design: J.A. Barta, N.R. Evans.Analysis and interpretation of the data: N.R. Evans.Drafting of the article: J.A. Barta, N.R. Evans, G.C. Kane, C.S. Shusted.Critical revision for important intellectual content: J.A. Barta, N.R. Evans, C.S. Shusted.Final approval of the article: J.A. Barta, N.R. Evans, G.C. Kane, C.S. Shusted.This article was published at Annals.org on 12 April 2022. PreviousarticleNextarticle Advertisement Annals Author Insight Video - Gregory C. Kane, MD; Nathaniel R. Evans, MD; Julie A. Barta, MD; and Christine S. Shusted, MPH In this video, Gregory C. Kane, MD; Nathaniel R. Evans, MD; Julie A. Barta, MD; and Christine S. Shusted, MPH, offer additional insight into the article, "Now Is the Time to Make Screening for Lung Cancer Reportable." (Duration 2:17) FiguresReferencesRelatedDetails Metrics Cited byTransPND: A Transformer Based Pulmonary Nodule Diagnosis Method on CT Image June 2022Volume 175, Issue 6Page: 888-889KeywordsCancer preventionCancer screeningCritical careLung and intrathoracic tumorsLung cancer screeningMedicaidMedicare ePublished: 12 April 2022 Issue Published: June 2022 Copyright & PermissionsCopyright © 2022 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...